The tissue factor–factor VIIa complex
The intrinsic pathway of coagulation
von Willebrand disease
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin®)
Inflammatory/hemostatic biomarkers and cardiovascular risk
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly
The bloody path of amyloids and prions
Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses
Evidence of a U-shaped association between factor XII activity and overall survival
Hereditary hemorrhagic telangiectasia
Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus
Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease
Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia
Role of elevated α2-macroglobulin revisited
High risk for venous thromboembolism in diabetics with hyperosmolar state
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials
A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects
Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis
Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions
Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet–leukocyte activation
Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer
Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis
Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio
The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease
Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity
Fibrinolysis in a lipid environment
Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL
Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets
The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins α5β1 and αvβ3
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells
Effect of wine phenolics on cytokine-induced C-reactive protein expression
Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116)1
Local tissue-type plasminogen activator release in patients with ischemic stroke
Thalidomide causes platelet activation, which can be abrogated by aspirin
Linkage analysis for three coagulation factors clustering on chromosome 13q34
Feasibility and accuracy of a rapid ‘point-of-care’ D-dimer test performed with a capillary blood sample
Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay
A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate
A mechanism to safeguard platelet adhesion under high-shear flow
A mechanism to safeguard platelet adhesion under high-shear flow
Corrigendum
ANNOUNCEMENTS